Standout Papers

Diagnostic criteria for mild cognitive impairment in Parkinson's di... 2006 2026 2012 2019 1.9k
  1. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines (2012)
    Irene Litvan, Jennifer G. Goldman et al. Movement Disorders
  2. Impulse Control Disorders in Parkinson Disease (2010)
    Daniel Weintraub, Juergen Koester et al. Archives of Neurology
  3. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease (2009)
    Sarra Nazem, Andrew Siderowf et al. Neurology
  4. The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease (2011)
    Klaus Seppi, Daniel Weintraub et al. Movement Disorders
  5. Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease (2006)
    Lon S. Schneider, Pierre N. Tariot et al. New England Journal of Medicine
  6. Parkinson disease-associated cognitive impairment (2021)
    Dag Aarsland, Lucia Batzu et al. Nature Reviews Disease Primers
  7. Cognitive decline in Parkinson disease (2017)
    Dag Aarsland, Byron Creese et al. Nature Reviews Neurology
  8. Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review (2019)
    Klaus Seppi, К. Ray Chaudhuri et al. Movement Disorders
  9. MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI (2011)
    Irene Litvan, Dag Aarsland et al. Movement Disorders
  10. Mild cognitive impairment in Parkinson disease (2010)
    Dag Aarsland, Kolbjørn Brønnick et al. Neurology
  11. Depression rating scales in Parkinson's disease: Critique and recommendations (2007)
    Anette Schrag, Paolo Barone et al. Movement Disorders
  12. Effect of Citalopram on Agitation in Alzheimer Disease (2014)
    Anton P. Porsteinsson, Lea T. Drye et al. JAMA
  13. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study (2016)
    Anette Schrag, Zacharias Anastasiou et al. The Lancet Neurology
  14. Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus (2024)
    Ines Debove, Steffen Paschen et al. Movement Disorders

Immediate Impact

18 from Science/Nature 117 standout
Sub-graph 1 of 19

Citing Papers

The pathogenesis of Parkinson's disease
2024 Standout
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
2024 Standout
8 intermediate papers

Works of Daniel Weintraub being referenced

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts
2023
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
2017
and 10 more

Author Peers

Author Last Decade Papers Cites
Daniel Weintraub 19387 7214 5737 359 26.8k
Christopher G. Goetz 26576 5581 6781 427 35.4k
David J. Burn 17614 6161 4619 369 25.6k
Anette Schrag 15961 3167 3047 308 21.5k
Jaime Kulisevsky 11532 4526 4771 318 17.3k
Dag Aarsland 24797 13490 8663 641 43.1k
Michael S. Okun 19770 2956 4498 701 28.3k
Karen Marder 11860 6278 3181 339 24.2k
Charles H. Adler 18831 3285 4188 307 24.8k
Ian G. McKeith 11204 11329 5115 363 26.6k
Irene Litvan 24179 5437 4848 334 32.4k

All Works

Loading papers...

Rankless by CCL
2026